Kairo Bio Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
1
Kairo Bio General Information
Description
Operator of an AI-powered functional immune mapping platform intended to predict immune responses and de-risk clinical development in immunology. The company is currently operating in Stealth Mode.
Contact Information
Website
www.kairo.bioCorporate Office
- 14 Avenue Du General De Gaulle
- 94160 Saint-Mandé
- France
Corporate Office
- 14 Avenue Du General De Gaulle
- 94160 Saint-Mandé
- France
Kairo Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Sep-2026 | Completed | Stealth |
Kairo Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kairo Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DayOne Accelerator | Accelerator/Incubator | Minority |
Kairo Bio FAQs
-
When was Kairo Bio founded?
Kairo Bio was founded in 2026.
-
Where is Kairo Bio headquartered?
Kairo Bio is headquartered in Saint-Mandé, France.
-
What industry is Kairo Bio in?
Kairo Bio’s primary industry is Other Healthcare Technology Systems.
-
Is Kairo Bio a private or public company?
Kairo Bio is a Private company.
-
What is Kairo Bio’s current revenue?
The current revenue for Kairo Bio is .
-
Who are Kairo Bio’s investors?
DayOne Accelerator has invested in Kairo Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
